Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese and Western medicines, chemical raw materials, natural and biological medicines, chemical raw material intermediates, and health products. It operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Great Medical Care. The company is also involved in the wholesale, retail, import, and export of Western medicines, Chinese medicines, and medical apparatus and instruments; investment in health industry with medical care, health management, health maintenance, elderly care, etc.; and research, development, production, and sale of beverage, food, healthcare products, cosmeceuticals, etc. It operates in the People's Republic of China. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was founded in 1997 and is based in Guangzhou, the People's Republic of China.
Kontrakty CFD to złożone instrumenty, które wiążą się z dużym ryzykiem gwałtownej straty środków na skutek zastosowania dźwigni finansowej. 70% inwestorów detalicznych odnotowuje straty w handlu kontraktami CFD z tym dostawcą. Powinieneś rozważyć, czy rozumiesz, jak działają kontrakty CFD i czy możesz sobie pozwolić na podjęcie wysokiego ryzyka utraty pieniędzy. Prosimy o zapoznanie się z naszym Oświadczeniem o ryzyku
Oceny i recenzje
Oceny i recenzje
